Skip to content
Join our community and subscribe to our free weekly newsletter
Subscribe
Toggle Navigation
Latest News
Articles
Live Talks
Trials Update
Prevention & Risk Factors
Science-Backed Dementia Prevention
Alzheimer’s Genetics & Risk Factors
Menopause
Long COVID
Dementias
Alzheimer’s Disease
Vascular Dementia
Frontotemporal Dementia (FTD)
Lewy Body Dementia
Traumatic Brain Injury & CTE
Brain Disorders
Mild Cognitive Impairment (MCI)
Parkinson’s Disease
Getting Diagnosed
Diagnosis
Journey to Diagnosis
Genetic Testing
Alzheimer’s Biomarkers
Diversity and Dementia
Caregivers
Caregiver Voices
Learning Guides
Search for:
Search for:
Latest news
Artificial Intelligence Analyzes Blood Samples, Accurately Predicts Alzheimer’s
Researchers Explore Lithium as Treatment for Alzheimer’s Disease
FDA Gives Biogen Green Light to Relaunch Aducanumab Study on Trial Participants
Bigger Risk for Smaller Brains: Concussions in Youth Football
Living Close to Major Roads or Highways Linked to Dementia
Windows to the Brain: Retinal Testing for Alzheimer’s
Researchers Pinpoint Protein, ‘Aggregatin,’ as New Biomarker for Alzheimer’s
Is Soybean Oil Harmful For the Brain? New Study Examines Health Impact
‘Pharmacological Chaperones’ May Help Treat Alzheimer’s By Clearing Harmful Proteins From Brain
Ovarian Cancer Protein May Worsen Alzheimer’s Neurodegeneration
New Alzheimer’s Drug Improves Learning and Memory in Mice
Screening For Dementia in Primary Care to Improve Early Detection
Scientists Seek Vascular Dementia Treatment By Studying Blood Flow in the Brain
Researchers Explore How Antibiotics May Help Treat Frontotemporal Dementia
Biogen Plans to Buy Early-Stage Alzheimer’s and Parkinson’s Treatment From Pfizer
Previous
103
104
105
Next
Page load link
Go to Top